JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, B. B.
Right arrow Articles by Wong, A. S.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, B. B.
Right arrow Articles by Wong, A. S.Y.
Related Collections
Right arrow Regional Anesthesia
Right arrow Pharmacology

Anesth Analg 2002;95:1402-1407
© 2002 International Anesthesia Research Society


REGIONAL ANESTHESIA

The Effect of the Addition of Epinephrine on Early Systemic Absorption of Epidural Ropivacaine in Humans

Bee B. Lee, FANZCA FHKCA, FHKAM*, Warwick D. Ngan Kee, MD FANZCA, FHKCA, FHKAM*, John L. Plummer, PhD AStat{dagger}, Manoj K. Karmakar, FRCA FHKCA*, and April S.Y. Wong, BSc*

*Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China; and {dagger}Department of Anaesthesia, Flinders Medical Centre, Flinders University of South Australia, Bedford Park, South Australia, Australia

Address correspondence and reprint requests to Bee Beng Lee, MD, Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China. Address e-mail to bblee{at}cuhk.edu.hk

The addition of epinephrine to ropivacaine has not been recommended because ropivacaine has intrinsic vasoconstrictor properties. However, few pharmacokinetic data are available on the addition of epinephrine to epidural ropivacaine in humans. In this prospective, double-blinded study, we randomized patients having elective abdominal hysterectomy to receive epidural ropivacaine 1.5 mg/kg, diluted in 15 mL, either with (epinephrine group, n = 12) or without (plain group, n = 12) epinephrine 5 µg/mL and then measured arterial and venous plasma concentrations of ropivacaine at intervals up to 180 min. We found that arterial and venous plasma ropivacaine concentrations were smaller in the epinephrine group compared with the plain group in the first 60 min after the drug administration (P < 0.01). Mean (± SD) maximum total plasma ropivacaine concentration was smaller in the epinephrine group (arterial, 0.92 ± 0.32 µg/mL; venous, 0.82 ± 0.33 µg/mL) compared with the plain group (1.31 ± 0.39 µg/mL and 1.31 ± 0.50 µg/mL, respectively; P = 0.01). Time to maximum total plasma ropivacaine concentration was not significantly different between groups (mean ± SD; arterial, 16 ± 2 min; venous, 23 ± 2 min in the epinephrine group versus 9 ± 2 min and 12 ± 3 min, respectively, in the plain group; P = 0.08). Arterial plasma ropivacaine concentrations were larger than venous concentrations during the first hour (P < 0.01); the arterio-venous difference decreased exponentially, and the rate and magnitude of this decrease was unaffected by epinephrine. We conclude that the addition of epinephrine 5 µg/mL to ropivacaine reduced the early systemic plasma concentrations of ropivacaine after epidural injection and may be useful for decreasing the risk of toxicity from systemic absorption of epidural ropivacaine.

IMPLICATIONS: The addition of epinephrine 5 µg/mL to epidural ropivacaine reduced the systemic arterial and venous plasma concentrations of ropivacaine in the first hour and the maximum plasma concentration of ropivacaine. Epinephrine may be a useful additive for reducing the risk of systemic toxicity when large doses of ropivacaine are given epidurally.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
M. Ratajczak-Enselme, J.-P. Estebe, F.-X. Rose, E. Wodey, J.-M. Malinovsky, F. Chevanne, G. Dollo, C. Ecoffey, and P. Le Corre
Effect of epinephrine on epidural, intrathecal, and plasma pharmacokinetics of ropivacaine and bupivacaine in sheep
Br. J. Anaesth., December 1, 2007; 99(6): 881 - 890.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. J. G. Simon, B. T. Veering, A. A. Vletter, R. Stienstra, J. W. van Kleef, and A. G. L. Burm
The Effect of Age on the Systemic Absorption and Systemic Disposition of Ropivacaine after Epidural Administration
Anesth. Analg., January 1, 2006; 102(1): 276 - 282.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Ishiyama, S. Kashimoto, T. Oguchi, T. Yamaguchi, K. Okuyama, and T. Kumazawa
Epidural Ropivacaine Anesthesia Decreases the Bispectral Index During the Awake Phase and Sevoflurane General Anesthesia
Anesth. Analg., March 1, 2005; 100(3): 728 - 732.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2002 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2002 by the International Anesthesia Research Society.